DuPont de Nemours, Inc. · 2026-11-03 · Importance 17 · Surprise 22
Third-quarter 2026 R&D expense decreased 19% to $42 million from $52 million, and R&D declined to 2% of sales from 3%. Nine-month R&D expense fell 15% to $131 million from $155 million, with R&D at 2% of sales versus 3%. DuPont said 2025 R&D included indirect corporate and shared-service costs previously allocated to the Electronics and Aramids businesses that remained in continuing operations.
Key facts
Third-quarter 2026 R&D expense was $42 million, down from $52 million in third-quarter 2025; R&D was 2 percent versus 3 percent of net sales. source
R&D expense for the first nine months of 2026 was $131 million, down from $155 million in 2025; R&D was 2 percent versus 3 percent of net sales. source